Paroxysmal atrial fibrillation
MONDO:1030011An atrial fibrillation disorder characterized by intermittent atrial fibrillation that lasts less than seven days from onset.
Also known as: paroxymsal AFib, paroxysmal AF
167 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
Heart device study halted early – what we know
Disease control TerminatedThis study looked at how well the DiamondTemp ablation system controls atrial fibrillation (a type of irregular heartbeat) over three years. It included 84 adults with paroxysmal AF who had not responded to medication. The study was terminated early, so the full results are not a…
Sponsor: Medtronic Cardiac Ablation Solutions • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
AFib ablation study halted early – what it means for patients
Disease control TerminatedThis study compared two types of heart ablation for people with paroxysmal atrial fibrillation (AFib). One group received standard pulmonary vein isolation, while the other also had the back wall of the left atrium isolated. Both used a newer technique called pulsed-field ablatio…
Phase: NA • Sponsor: Jorge Romero • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Kidney nerve treatment studied for stubborn heart rhythm problem
Disease control TerminatedThis study looked at whether a procedure called renal denervation could help people with recurrent atrial fibrillation (an irregular heartbeat) that keeps coming back even after standard treatment. The procedure uses energy to calm certain nerves near the kidneys. Only 6 people t…
Phase: NA • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Frozen heart fix: new device targets AFib
Disease control TerminatedThis study tested a medical device that freezes small areas of heart tissue to treat atrial fibrillation (AFib) and related irregular heartbeats. The goal was to see if the procedure safely stops abnormal rhythms for at least 12 months. The study enrolled 91 people, but was termi…
Phase: NA • Sponsor: Adagio Medical • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC